​

Sutro Biopharma (STRO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Sutro Biopharma Revenue Highlights

Latest Revenue (Y)

$62.04M

Latest Revenue (Q)

$25.71M

Main Segment (Y)

Research and Development Services

Main Geography (Y)

Collaboration Revenue

Sutro Biopharma Revenue by Period

Sutro Biopharma Revenue by Year

DateRevenueChange
2024-12-31$62.04M-59.64%
2023-12-31$153.73M126.84%
2022-12-31$67.77M9.52%
2021-12-31$61.88M44.84%
2020-12-31$42.72M-0.03%
2019-12-31$42.74M11.24%
2018-12-31$38.42M-25.75%
2017-12-31$51.74M-13.38%
2016-12-31$59.73M-

Sutro Biopharma generated $62.04M in revenue during NA 2024, up -59.64% compared to the previous quarter, and up 145.18% compared to the same period a year ago.

Sutro Biopharma Revenue by Quarter

DateRevenueChange
2024-06-30$25.71M97.62%
2024-03-31$13.01M-88.56%
2023-12-31$113.72M571.95%
2023-09-30$16.92M62.54%
2023-06-30$10.41M-17.85%
2023-03-31$12.67M46.83%
2022-12-31$8.63M-65.67%
2022-09-30$25.15M-10.50%
2022-06-30$28.10M376.45%
2022-03-31$5.90M-44.65%
2021-12-31$10.65M25.09%
2021-09-30$8.52M-69.64%
2021-06-30$28.05M91.33%
2021-03-31$14.66M77.10%
2020-12-31$8.28M-53.55%
2020-09-30$17.82M88.22%
2020-06-30$9.47M32.40%
2020-03-31$7.15M-36.74%
2019-12-31$11.30M-7.92%
2019-09-30$12.28M16.65%
2019-06-30$10.53M21.97%
2019-03-31$8.63M-54.79%
2018-12-31$19.09M143.57%
2018-09-30$7.84M37.38%
2018-06-30$5.70M-1.54%
2018-03-31$5.79M43.39%
2017-12-31$4.04M-76.91%
2017-09-30$17.50M15.88%
2017-06-30$15.10M-
2017-03-31$15.10M-

Sutro Biopharma generated $25.71M in revenue during Q2 2024, up 97.62% compared to the previous quarter, and up 202.82% compared to the same period a year ago.

Sutro Biopharma Revenue Breakdown

Sutro Biopharma Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 18
Research and Development Services$174.00K-
Other Revenue-$5.42M
Collaboration Revenue-$13.54M

Sutro Biopharma's latest annual revenue breakdown by segment (product or service), as of Dec 24: Research and Development Services (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 18Sep 18
Other Revenue$654.00K$912.00K
Collaboration Revenue$18.43M-

Sutro Biopharma's latest quarterly revenue breakdown by segment (product or service), as of Dec 18: Collaboration Revenue (96.57%), and Other Revenue (3.43%).

Sutro Biopharma Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 18
Collaboration Revenue$13.54M
Other Revenue$5.42M

Sutro Biopharma's latest annual revenue breakdown by geography, as of Dec 18: Collaboration Revenue (71.40%), and Other Revenue (28.60%).

Quarterly Revenue by Country

CountryDec 18Sep 18
Other Revenue$654.00K$912.00K
Collaboration Revenue$18.43M-

Sutro Biopharma's latest quarterly revenue breakdown by geography, as of Dec 18: Collaboration Revenue (96.57%), and Other Revenue (3.43%).

Sutro Biopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ANABAnaptysBio$91.28M$30.02M
STROSutro Biopharma$62.04M$25.71M
MRUSMerus$36.13M$11.77M
MGTXMeiraGTx$33.28M$10.91M
SNDXSyndax Pharmaceuticals$23.68M$12.50M
IDYAIDEAYA Biosciences$7.00M-
KROSKeros Therapeutics$3.55M$37.00K
OPTOpthea$108.41K$61.27K
PCVXVaxcyte--
REPLReplimune Group--
AVTEAerovate Therapeutics--
GNTAGenenta Science S.p.A.--
CNTACentessa Pharmaceuticals--
MLYSMineralys Therapeutics--
HLVXHilleVax--
LRMRLarimar Therapeutics--

STRO Revenue FAQ

What is Sutro Biopharma’s yearly revenue?

Sutro Biopharma's yearly revenue for 2024 was $62.04M, representing a decrease of -59.64% compared to 2023. The company's yearly revenue for 2023 was $153.73M, representing an increase of 126.84% compared to 2022. STRO's yearly revenue for 2022 was $67.77M, representing an increase of 9.52% compared to 2021.

What is Sutro Biopharma’s quarterly revenue?

Sutro Biopharma's quarterly revenue for Q2 2024 was $25.71M, a 97.62% increase from the previous quarter (Q1 2024), and a 146.89% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $13.01M, a -88.56% decrease from the previous quarter (Q4 2023), and a 2.64% increase year-over-year (Q1 2023). STRO's quarterly revenue for Q4 2023 was $113.72M, a 571.95% increase from the previous quarter (Q3 2023), and a 1217.44% increase year-over-year (Q4 2022).

What is Sutro Biopharma’s revenue growth rate?

Sutro Biopharma's revenue growth rate for the last 3 years (2022-2024) was -8.45%, and for the last 5 years (2020-2024) was 45.22%.

What are Sutro Biopharma’s revenue streams?

Sutro Biopharma's revenue streams in c 24 are Research and Development Services

What is Sutro Biopharma’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Sutro Biopharma was Research and Development Services. This segment made a revenue of $174K, representing 100.00% of the company's total revenue.